These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36773106)

  • 21. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.
    Mirzaei M; Pushpitha K; Deng L; Chitranshi N; Gupta V; Rajput R; Mangani AB; Dheer Y; Godinez A; McKay MJ; Kamath K; Pascovici D; Wu JX; Salekdeh GH; Karl T; Haynes PA; Graham SL; Gupta VK
    Mol Neurobiol; 2019 Sep; 56(9):6017-6034. PubMed ID: 30707393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
    Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
    J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal arterial Aβ
    Shi H; Koronyo Y; Fuchs DT; Sheyn J; Jallow O; Mandalia K; Graham SL; Gupta VK; Mirzaei M; Kramerov AA; Ljubimov AV; Hawes D; Miller CA; Black KL; Carare RO; Koronyo-Hamaoui M
    Alzheimers Dement; 2023 Nov; 19(11):5185-5197. PubMed ID: 37166032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications.
    Wang L; Mao X
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33653000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.
    Koronyo Y; Salumbides BC; Black KL; Koronyo-Hamaoui M
    Neurodegener Dis; 2012; 10(1-4):285-93. PubMed ID: 22343730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease.
    Shi H; Koronyo Y; Fuchs DT; Sheyn J; Wawrowsky K; Lahiri S; Black KL; Koronyo-Hamaoui M
    Acta Neuropathol Commun; 2020 Nov; 8(1):202. PubMed ID: 33228786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease.
    Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation.
    Wang MD; Zhang S; Liu XY; Wang PP; Zhu YF; Zhu JR; Lv CS; Li SY; Liu SF; Wen L
    Acta Pharmacol Sin; 2023 Nov; 44(11):2151-2168. PubMed ID: 37420104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal ganglion cell loss and gliosis in the retinofugal projection following intravitreal exposure to amyloid-beta.
    Simons ES; Smith MA; Dengler-Crish CM; Crish SD
    Neurobiol Dis; 2021 Jan; 147():105146. PubMed ID: 33122075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.